Antimuscarinic Medication for Urgency Urinary Incontinence in Women With Dual Incontinence (Darifenacin for Treatment of Women With Dual Incontinence)
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2019
Price : $35 *
At a glance
- Drugs Darifenacin (Primary)
- Indications Faecal incontinence; Urinary incontinence
- Focus Therapeutic Use
- Acronyms BAMA
- 18 Jan 2019 Status changed from recruiting to completed.
- 13 Jun 2018 Status changed from not yet recruiting to recruiting.
- 05 Jun 2018 New trial record